(Q46620482)

English

Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment

scientific article published on 25 April 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

1 reference

based on heuristic

inferred from title

author name string

J Subiza

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

A Feliú

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

J L Subiza

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

J Uhlig

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

E Fernández-Caldas

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

publication date

25 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

38

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

987-994

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2008.02995.X

21 January 2018

The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2008.02995.X

21 January 2018

Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2008.02995.X

21 January 2018

Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2008.02995.X

21 January 2018

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2008.02995.X

21 January 2018

The major grass pollen group 5 allergen from Dactylis glomerata and its C-terminal split product both behave as dimers: implications for allergen standardization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2008.02995.X

21 January 2018

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2008.02995.X

21 January 2018

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2008.02995.X

21 January 2018

Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2008.02995.X

21 January 2018

Identifiers

10.1111/J.1365-2222.2008.02995.X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18445082

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46620482&oldid=2122651279"